Correlation Between Zentalis Pharmaceuticals and Spyre Therapeutics
Can any of the company-specific risk be diversified away by investing in both Zentalis Pharmaceuticals and Spyre Therapeutics at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zentalis Pharmaceuticals and Spyre Therapeutics into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Zentalis Pharmaceuticals Llc and Spyre Therapeutics, you can compare the effects of market volatilities on Zentalis Pharmaceuticals and Spyre Therapeutics and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zentalis Pharmaceuticals with a short position of Spyre Therapeutics. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zentalis Pharmaceuticals and Spyre Therapeutics.
Diversification Opportunities for Zentalis Pharmaceuticals and Spyre Therapeutics
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Zentalis and Spyre is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Zentalis Pharmaceuticals Llc and Spyre Therapeutics in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Spyre Therapeutics and Zentalis Pharmaceuticals is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zentalis Pharmaceuticals Llc are associated (or correlated) with Spyre Therapeutics. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Spyre Therapeutics has no effect on the direction of Zentalis Pharmaceuticals i.e., Zentalis Pharmaceuticals and Spyre Therapeutics go up and down completely randomly.
Pair Corralation between Zentalis Pharmaceuticals and Spyre Therapeutics
Given the investment horizon of 90 days Zentalis Pharmaceuticals Llc is expected to under-perform the Spyre Therapeutics. In addition to that, Zentalis Pharmaceuticals is 1.92 times more volatile than Spyre Therapeutics. It trades about -0.08 of its total potential returns per unit of risk. Spyre Therapeutics is currently generating about -0.09 per unit of volatility. If you would invest 2,254 in Spyre Therapeutics on December 28, 2024 and sell it today you would lose (485.00) from holding Spyre Therapeutics or give up 21.52% of portfolio value over 90 days.
Time Period | 3 Months [change] |
Direction | Moves Together |
Strength | Significant |
Accuracy | 100.0% |
Values | Daily Returns |
Zentalis Pharmaceuticals Llc vs. Spyre Therapeutics
Performance |
Timeline |
Zentalis Pharmaceuticals |
Spyre Therapeutics |
Zentalis Pharmaceuticals and Spyre Therapeutics Volatility Contrast
Predicted Return Density |
Returns |
Pair Trading with Zentalis Pharmaceuticals and Spyre Therapeutics
The main advantage of trading using opposite Zentalis Pharmaceuticals and Spyre Therapeutics positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zentalis Pharmaceuticals position performs unexpectedly, Spyre Therapeutics can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Spyre Therapeutics will offset losses from the drop in Spyre Therapeutics' long position.Zentalis Pharmaceuticals vs. Sana Biotechnology | Zentalis Pharmaceuticals vs. Olema Pharmaceuticals | Zentalis Pharmaceuticals vs. Cullinan Oncology LLC | Zentalis Pharmaceuticals vs. Monte Rosa Therapeutics |
Spyre Therapeutics vs. Plexus Corp | Spyre Therapeutics vs. Molecular Partners AG | Spyre Therapeutics vs. Allient | Spyre Therapeutics vs. Jabil Circuit |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Idea Analyzer module to analyze all characteristics, volatility and risk-adjusted return of Macroaxis ideas.
Other Complementary Tools
Portfolio Backtesting Avoid under-diversification and over-optimization by backtesting your portfolios | |
Equity Valuation Check real value of public entities based on technical and fundamental data | |
Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
Portfolio Analyzer Portfolio analysis module that provides access to portfolio diagnostics and optimization engine | |
Stocks Directory Find actively traded stocks across global markets |